Arthneeti
Latest: India Glycols Q1 FY27 results →All Q2 FY26 results →
G

India Glycols

Q2 FY26Beverages

India Glycols Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹332
Market cap₹2.2K Cr
P/E7.0
Updated16 Oct 2026
Read5 min read

The short version

Growth in premium brands like Amrut and organic brands is expected, with a steady increase in sales volume—targeting at least one case growth every day, aiming for consistent monthly growth and market share gains (Page 20). Biofuel segment is expected to grow in line with the blending program, supported by capacity additions and feedstock diversification, contributing to topline and EBIT growth (Q2 FY26: revenue up 63%, EBIT up 121% YoY).

From India Glycols's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Growth in premium brands like Amrut and organic brands is expected, with a steady increase in sales volume—targeting at least one case growth every day, aiming for consistent monthly growth and market share gains (Page 20).
  • Biofuels segment shows strong growth, with volumes supplied (~15 crore liters in FY '24-'25) expected to rise in line with blending programs aiming for 20% blending in FY '25-'26 and potential increase to 27% beyond 2026 (Page 6).
  • Chemicals business expects incremental capacity additions with modular expansion, with CAPEX plans between INR 10-50 crore depending on opportunities, supporting volume growth in new and value-added chemicals (Page 17).

2 more points from India Glycols's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what India Glycols said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • India Glycols is adding incremental specialty chemicals capacity over the next few months to one year with modular manufacturing expansions.
  • Planned CAPEX in the range of INR 10 crores to INR 50 crores depending on project progression and new large-volume contracts.
  • No huge CAPEX expected in the next year due to brownfield site advantages and existing assets.
  • Exploring newer technologies and potential growth areas in specialty chemicals and biofuels.
  • For branded nutraceuticals, investments are ongoing for certifications and registrations in the U.S. and Europe to facilitate future sales.
  • The focus is on long-term growth through innovation rather than heavy upfront investment.

2 more points from India Glycols's call on capex

Create a free account to keep reading this call

Top-ranked in Beverages

Ranked on what management guided this quarter

Guidance-ranked
1Piccadily Agro Industries Ltd
Rev 1Mar 3
2Varun Beverages
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 3Mar 1
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what India Glycols said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The ethanol supply year ends on October 31, and India Glycols is on track to supply based on the existing order book.
  • Oil Marketing Companies (OMCs) have given partial allocations so far; complete allocations for the next year are pending and expected to be clearer in the coming months.
  • The existing unexecuted order book related to ethanol from OMCs was previously around INR 1,100 to 1,200 crore.
  • Traction from OMCs remains good, with the 20% ethanol blending mandate expected to sustain and potentially grow, driving steady demand.

2 more points from India Glycols's call on order book

Create a free account to keep reading this call

India Glycols — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹976 Cr, net profit ₹87 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What India Glycols's management said in earlier quarters

Others in Beverages this season

  • Tilaknagar Industries Ltd (Q2 FY26)

    PAT adjusted for subsidy saw 10% YoY growth in Q2 and 24.5% growth for H1 FY26, indicating profitability momentum. Key concall takeaways from Tilaknagar…

  • Piccadily Agro Industries Ltd (Q2 FY26)

    Q2 FY2025-26 Revenue from operations: ₹232.7 crore, up 16.1% YoY . Key investor presentation takeaways from Piccadily Agro Industries Ltd's Q2 FY26 investor pre

  • United Spirits Ltd (Q2 FY26)

    . Key concall takeaways from United Spirits Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

  • Radico Khaitan Ltd (Q2 FY26)

    400-425 crore per quarter with continued double-digit growth in country liquor segment. Key concall takeaways from Radico Khaitan's Q2 FY26 earnings call — and…

Compare:vs Varun Beverages Ltdvs United Spirits Ltdvs Radico Khaitan Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

India Glycols and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were India Glycols Q2 FY26 results?

Growth in premium brands like Amrut and organic brands is expected, with a steady increase in sales volume—targeting at least one case growth every day, aiming for consistent monthly growth and market share gains (Page 20). Biofuel segment is expected to grow in line with the blending program, supported by capacity additions and feedstock diversification, contributing to topline and EBIT growth (Q2 FY26: revenue up 63%, EBIT up 121% YoY).

What is India Glycols share price analysis?

India Glycols currently shows a neutral. The stock trades at a P/E of 7.0 with a market cap of ₹2,225 Cr. Investors should review the full earnings analysis for detailed insights.

Is India Glycols planning capital expenditure?

India Glycols is adding incremental specialty chemicals capacity over the next few months to one year with modular manufacturing expansions. - Planned CAPEX in the range of INR 10 crores to INR 50 crores depending on project progression and new large-volume contracts. - No huge CAPEX expected in the next year due to brownfield site advantages and existing assets. - Exploring newer technologies and potential growth areas in specialty chemicals and biofuels. - For branded nutraceuticals, investments are ongoing for certifications and registrations in the U.S.

Keep India Glycols on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.